MarketPeel
Insider Trading Intelligence
Pricing
…
AH

Alexandra Hughes-wilson

MREO
SEE REMARKS · MEREO BIOPHARMA GROUP PLC · CIK 0002005875
FILING MIX · LIFETIME44%/56%
BUYS
12
SELLS
15
TOTAL VALUE
$1.96M
COMPANIES
1
ACTIVE SINCE
Jan 2024
HOLDINGS NOW
183,750
AVG SELL PX
$2.26
TRADE KIND
SHOWING 27 / 27
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
8 backtested trades · 8 horizons · 4 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Alexandra Hughes-wilson, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d8+62.50%+2.72%+0.94%+1.78%-2.12%—
14d8+50.00%+4.05%+2.01%+2.04%-0.07%—
30d8+25.00%+13.56%+2.67%+10.88%+8.95%—
60d8+50.00%+16.29%+5.49%+10.80%+9.08%—
90d8+50.00%+9.95%+6.90%+3.05%-4.86%—
180d8+75.00%-18.78%+5.41%-24.19%-26.87%—
1y8+100.00%-39.60%+15.27%-54.88%-55.03%—
2y8(4 pending)+100.00%-91.42%+38.24%-129.66%-129.66%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
MREO · 183,750 shares · as of Feb 1, 2026
060,720121,441182,161242,88120252026SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2024
2024
2024
2024
2025
2025
2025
2025
2026
FLOW · 12 buys / 15 sellsCOVERAGE · 9 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
MREO
MEREO BIOPHARMA GROUP PLC
PURCHASEGRANT
Stock grant
195,000——195,000Feb 1, 2026Feb 2, 2026 ↗View →
MREO
MEREO BIOPHARMA GROUP PLC
PURCHASEGRANT
Stock grant
61,250——61,250Feb 1, 2026Feb 2, 2026 ↗View →
MREO
MEREO BIOPHARMA GROUP PLC
PURCHASEGRANT
Stock grant
183,750——183,750Feb 1, 2026Feb 2, 2026 ↗View →
MREO
MEREO BIOPHARMA GROUP PLC
PURCHASEGRANT
Stock grant
154,000——154,000Jan 25, 2025Jan 28, 2025 ↗View →
MREO
MEREO BIOPHARMA GROUP PLC
SALE
See Remarks
84,008$4.22$354.6K50,475Sep 13, 2024Sep 16, 2024 ↗View →
MREO
MEREO BIOPHARMA GROUP PLC
SALE
See Remarks
16,304$4.22$68.8K134,483Sep 13, 2024Sep 16, 2024 ↗View →
MREO
MEREO BIOPHARMA GROUP PLC
SALE
See Remarks
7,769$4.47$34.7K190,816Sep 12, 2024Sep 16, 2024 ↗View →
MREO
MEREO BIOPHARMA GROUP PLC
SALE
See Remarks
40,029$4.47$179.0K150,787Sep 12, 2024Sep 16, 2024 ↗View →
MREO
MEREO BIOPHARMA GROUP PLC
PURCHASE
See Remarks
40,000——74,548Sep 11, 2024Sep 13, 2024 ↗View →
MREO
MEREO BIOPHARMA GROUP PLC
SALE
See Remarks
75,000$1.01$75.8K0Sep 11, 2024Sep 13, 2024 ↗View →
MREO
MEREO BIOPHARMA GROUP PLC
PURCHASE
See Remarks
93,333$1.40$130.7K167,881Sep 11, 2024Sep 13, 2024 ↗View →
MREO
MEREO BIOPHARMA GROUP PLC
SALE
See Remarks
93,333$1.40$130.7K0Sep 11, 2024Sep 13, 2024 ↗View →
MREO
MEREO BIOPHARMA GROUP PLC
PURCHASE
See Remarks
75,000$1.01$75.8K242,881Sep 11, 2024Sep 13, 2024 ↗View →
MREO
MEREO BIOPHARMA GROUP PLC
SALE
See Remarks
40,000——0Sep 11, 2024Sep 13, 2024 ↗View →
MREO
MEREO BIOPHARMA GROUP PLC
SALE
See Remarks
22,968$3.39$77.9K34,548Jun 26, 2024Jun 27, 2024 ↗View →
MREO
MEREO BIOPHARMA GROUP PLC
SALE
See Remarks
10,134$3.69$37.4K57,516Jun 25, 2024Jun 27, 2024 ↗View →
MREO
MEREO BIOPHARMA GROUP PLC
PURCHASE
See Remarks
60,000——40,000Jun 21, 2024Jun 25, 2024 ↗View →
MREO
MEREO BIOPHARMA GROUP PLC
PURCHASE
See Remarks
60,000——67,650Jun 21, 2024Jun 25, 2024 ↗View →
MREO
MEREO BIOPHARMA GROUP PLC
SALE
See Remarks
50,082$2.94$147.2K32,568May 22, 2024May 23, 2024 ↗View →
MREO
MEREO BIOPHARMA GROUP PLC
SALE
See Remarks
42,983$1.40$60.2K7,650May 22, 2024May 23, 2024 ↗View →
MREO
MEREO BIOPHARMA GROUP PLC
PURCHASE
See Remarks
75,000$1.01$75.8K82,650May 22, 2024May 23, 2024 ↗View →
MREO
MEREO BIOPHARMA GROUP PLC
SALE
See Remarks
93,333$1.40$130.7K0May 22, 2024May 23, 2024 ↗View →
MREO
MEREO BIOPHARMA GROUP PLC
SALE
See Remarks
50,350$2.99$150.5K58,633May 22, 2024May 23, 2024 ↗View →
MREO
MEREO BIOPHARMA GROUP PLC
SALE
See Remarks
24,918$1.01$25.2K7,650May 22, 2024May 23, 2024 ↗View →
MREO
MEREO BIOPHARMA GROUP PLC
SALE
See Remarks
75,000$1.01$75.8K0May 22, 2024May 23, 2024 ↗View →
MREO
MEREO BIOPHARMA GROUP PLC
PURCHASE
See Remarks
93,333$1.40$130.7K100,983May 22, 2024May 23, 2024 ↗View →
MREO
MEREO BIOPHARMA GROUP PLC
PURCHASEGRANT
Stock grant
196,000——196,000Jan 25, 2024Jan 26, 2024 ↗View →
Other insiders · MREO
Loading peer insiders…
About this filer
CIK 0002005875
ROLE
See Remarks
PRIMARY
MREO
COMPANIES
1
ACTIVE SINCE
Jan 2024
MARKETPEEL · /INSIDER/0002005875DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback